Rationale and design of the ELEANOR trial early aortic valve surgery versus watchful waiting strategy in severe asymptomatic aortic regurgitation, ACRONYM: ELEANOR

Background: The optimal treatment of patients with severe symptomatic aortic regurgitation (AR) is state-of-the-art surgery. Asymptomatic patients with advanced left ventricular (LV) dilatation and/or impaired ejection fraction should undergo surgical treatment, but there is no guidelines consensus...

Full description

Bibliographic Details
Main Authors: Radka Kočková, Jan Vojáček, Helena Bedáňová, Petr Fila, Ivo Skalský, Daniela Žáková, Michal Klán, Barbora Míková, Karel Mědílek, Martin Tuna, Monika Fialová, Radka Dvořáková, Zuzana Hlubocká, Roman Panovský, Kryštof Slabý, Elayne Kelen de Oliveira, Filip Casselman, Martin Pěnička
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024055014